Idiopathic erythema annulare centrifugum successfully treated with doxycycline: A viable therapeutic option?
Skin Research and Technology · 2023
DOI: 10.1111/srt.13477 ↗Kurz gefasst
Leserbrief in der Zeitschrift Skin Research and Technology, 2023. Verfasst von Cristian Fidanzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Dermatology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Doxycycline, Skin Diseases, Genetic. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Erythema annulare centrifugum (EAC) is an inflammatory skin disease with unknown etiopathogenesis. 1 It is thoughtF I G U R E 1 Arcuate erythematous lesions due to erythema annulare centrifugum and subsequent disappearance of the lesions.(A)-(C) Initial clinical image depicting arcuate erythematous plaques with central clearing and advancing edge scattered all over the back and lower extremities.(D)-(F) Complete resolution of the skin lesions after 6 months of therapy with oral doxycycline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit of Dermatology, University of Pisa, Pisa, Italy.
ORCID-Profile: Cristian Fidanzi, Valentina Dini, Agata Janowska
Zitieren
APA
Fidanzi, C., Bevilacqua, M., Salvia, G., Romanelli, M., Dini, V., & Janowska, A. (2023). Idiopathic erythema annulare centrifugum successfully treated with doxycycline: A viable therapeutic option?. Skin Research and Technology. https://doi.org/10.1111/srt.13477
Vancouver
Fidanzi C, Bevilacqua M, Salvia G, Romanelli M, Dini V, Janowska A. Idiopathic erythema annulare centrifugum successfully treated with doxycycline: A viable therapeutic option?. Skin Research and Technology. 2023. doi:10.1111/srt.13477
BibTeX
@article{Fidanzi2023,
author = {Fidanzi, Cristian and Bevilacqua, Matteo and Salvia, Giorgia and Romanelli, Marco and Dini, Valentina and Janowska, Agata},
title = {Idiopathic erythema annulare centrifugum successfully treated with doxycycline: A viable therapeutic option?},
journal = {Skin Research and Technology},
year = {2023},
doi = {10.1111/srt.13477}
}
EUVIMED